Fosfomycin in continuous or prolonged infusion for systemic bacterial infections: a systematic review of its dosing regimen proposal from in vitro, in vivo and clinical studies

Fosfomycin (FOS) administered intravenously has been recently rediscovered for the treatment of systemic infections due to multidrug-resistant bacteria. Its pharmacokinetic properties suggest a time-dependent dosing schedule with more clinical benefits from prolonged (PI) or continuous infusion (CI)...

Descripción completa

Detalles Bibliográficos
Autores principales: Antonello, Roberta Maria, Di Bella, Stefano, Maraolo, Alberto Enrico, Luzzati, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139892/
https://www.ncbi.nlm.nih.gov/pubmed/33604721
http://dx.doi.org/10.1007/s10096-021-04181-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139892/
https://www.ncbi.nlm.nih.gov/pubmed/33604721
http://dx.doi.org/10.1007/s10096-021-04181-x

Ejemplares similares